a month ago
ADPT
AnalystsSubbu NambiSubbu Nambi's Stock Forecasts
AnalystsSubbu Nambi
Analyst Ranking
Top 2%
#60 out of 5557 analysts
Average Return
+61.13%
Win Rate
65%71 out of 110
Risk vs Reward
Poor
Good
Subbu Nambi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exact Sciences CorpEXAS | +4,095.93% | $44.45 | $1,865.09 | 2025-04-11 - 2026-03-24 | Strong Buy |
Guardant Health IncGH | +193.20% | $60.18 | $176.45 | 2025-09-25 - 2026-09-24 | Strong Buy |
Natera IncNTRA | +176.34% | $60.27 | $166.55 | 2023-12-14 - 2024-12-13 | Strong Buy |
Twist Bioscience CorpTWST | +169.01% | $42.46 | $114.22 | 2026-01-26 - 2026-11-12 | Strong Buy |
Twist Bioscience CorpTWST | +164.03% | $43.26 | $114.22 | 2026-03-30 - 2026-11-12 | Strong Buy |
Subbu Nambi Analyst Color
Get additional color on Subbu Nambi's coverage of popular stocks
a month ago
BLLN
a month ago
CYRX
a month ago
GH
a month ago
GRAL
a month ago
NTRA
a month ago
WAT
a month ago
WGS
a month ago
NEOG
3 months ago
NTRA
3 months ago
ADPT
4 months ago
GH
4 months ago
WGS
4 months ago
VCYT
4 months ago
TWST
4 months ago
NTRA
4 months ago
GH
4 months ago
BLLN
4 months ago
ADPT
6 months ago
BLLN
6 months ago
TWST
6 months ago
CYRX
7 months ago
TWST
9 months ago
NAUT
10 months ago
TWST
Subbu Nambi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Adaptive Biotechnologies CorpADPT | 7 | Strong Buy | $34.00 | +15.33% | Maintains | 3 days ago |
Billiontoone IncBLLN | 5 | Strong Buy | $128.00 | +15.53% | Maintains | a month ago |
Bruker CorpBRKR | 8 | Strong Buy | $72.00 | +19.34% | Maintains | a month ago |
Cryoport IncCYRX | 4 | Strong Buy | $19.00 | -5.47% | Maintains | a month ago |
Danaher CorpDHR | 6 | Strong Buy | $250.00 | +7.68% | Maintains | a month ago |
Guardant Health IncGH | 11 | Strong Buy | $200.00 | +29.15% | Maintains | a month ago |
Grail IncGRAL | 5 | Strong Buy | $155.00 | +27.73% | Maintains | a month ago |
Illumina IncILMN | 9 | Strong Buy | $305.00 | +45.55% | Maintains | a month ago |
Natera IncNTRA | 6 | Strong Buy | $475.00 | +47.09% | Maintains | a month ago |
Tempus Ai IncTEM | 7 | Strong Buy | $92.00 | +21.23% | Maintains | a month ago |
Twist Bioscience CorpTWST | 7 | Strong Buy | $212.00 | +85.61% | Maintains | a month ago |
Waters CorpWAT | 3 | Strong Buy | $490.00 | +6.01% | Maintains | a month ago |
Genedx Holdings CorpWGS | 6 | Strong Buy | $83.00 | +60.02% | Maintains | a month ago |
Neogen CorpNEOG | 5 | Strong Buy | $14.00 | +25.11% | Maintains | a month ago |
Freenome IncFRNM | 1 | Strong Buy | $21.00 | +97.93% | Initiates Coverage On | 3 months ago |
Veracyte IncVCYT | 7 | Strong Buy | $65.00 | +163.91% | Maintains | 4 months ago |
Nautilus Biotechnology IncNAUT | 2 | Strong Buy | $4.00 | +68.07% | Maintains | 9 months ago |
Sophia Genetics SaSOPH | 2 | Strong Buy | $7.00 | -10.94% | Maintains | 10 months ago |
Personalis IncPSNL | 2 | Strong Buy | $13.00 | -18.03% | Maintains | 10 months ago |
Castle Biosciences IncCSTL | 3 | Strong Buy | $47.00 | +36.23% | Maintains | 10 months ago |
Exact Sciences CorpEXAS | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Revvity IncRVTY | 1 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Caris Life Sciences IncCAI | 2 | Strong Buy | $36.00 | N/A | Maintains | a year ago |
Myriad Genetics IncMYGN | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
10x Genomics IncTXG | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Repligen CorpRGEN | 1 | Hold | N/A | N/A | Initiates Coverage On | 2 years ago |
Pacific Biosciences Of California IncPACB | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Akoya Biosciences IncAKYA | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.